Duration of treatment for osteoporosis
Many treatments for postmenopausal osteoporosis with proven efficacy in lowering fracture risk had become available since many years now. In the last few years the issue about treatment duration has become a matter of importance. In this paper the pivotal trials for alendronate, risedronate, zoledro...
Saved in:
Main Authors: | Luca Idolazzi (Author), A. Fassio (Author), D. Gatti (Author), S. Tamanini (Author), O. Viapiana (Author), M. Rossini (Author), S. Adami (Author) |
---|---|
Format: | Book |
Published: |
PAGEPress Publications,
2013-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Insight into the WNT system and its drug related response
by: S. Tamanini, et al.
Published: (2013) -
A case of mandible Paget's disease of the bone treated with intravenous neridronate
by: A. Fassio, et al.
Published: (2016) -
Clinical development of neridronate: potential for new applications
by: Gatti D, et al.
Published: (2013) -
Drug-induced osteonecrosis of the jaw: the state of the art
by: A. Fassio, et al.
Published: (2017) -
The negative bone effects of the disease and of chronic corticosteroid treatment in premenopausal women affected by rheumatoid arthritis
by: A. Fassio, et al.
Published: (2016)